Literature DB >> 10774827

Variable pulmonary responses from exposure to concentrated ambient air particles in a rat model of bronchitis.

U P Kodavanti1, R Mebane, A Ledbetter, T Krantz, J McGee, M C Jackson, L Walsh, H Hilliard, B Y Chen, J Richards, D L Costa.   

Abstract

Chronic bronchitis may be considered a risk factor in particulate matter (PM)-induced morbidity. We hypothesized that a rat model of human bronchitis would be more susceptible to the pulmonary effects of concentrated ambient particles (CAPs) from Research Triangle Park, NC. Bronchitis was induced in male Sprague-Dawley rats (90-100 days of age) by exposure to 200 ppm sulfur dioxide (SO2), 6 h/day x 5 days/week x 6 weeks. One day following the last SO2 exposure, both healthy (air-exposed) and bronchitic (SO2-exposed) rats were exposed to filtered air (three healthy; four bronchitic) or CAPs (five healthy; four bronchitic) by whole-body inhalation, 6 h/day x 2 or 3 days. Pulmonary injury was determined either immediately (0h) or 18 h following final CAPs exposure. The study protocol involving 0 h time point was repeated four times (study #A, November, 1997; #B, February, 1998; #C and #D, May, 1998), whereas the study protocol involving 18 h time point was done only once (#F). In an additional study (#E), rats were exposed to residual oil fly ash (ROFA), approximately 1 mg/ m(3)x6 h/day x 3 days to mimic the CAPs protocol (February, 1998). The rats allowed 18 h recovery following CAPs exposure (#F) did not depict any CAPs-related differences in bronchoalveolar lavage fluid (BALF) injury markers. Of the four CAPs studies conducted (0 h time point), the first (#A) study (approximately 650 microg/m3 CAPs) revealed significant changes in the lungs of CAPs-exposed bronchitic rats compared to the clean air controls. These rats had increased BALF protein, albumin, N-acetyl glutaminidase (NAG) activity and neutrophils. The second (#B) study (approximately 475 microg/m3 CAPs) did not reveal any significant effects of CAPs on BALF parameters. Study protocols #C (approximately 869 microg/m3 CAPs) and #D (approximately 907 microg/m3 CAPs) revealed only moderate increases in the above mentioned BALF parameters in bronchitic rats exposed to CAPs. Pulmonary histologic evaluation of studies #A, #C, #D, and #F revealed marginally higher congestion and perivascular cellularity in CAPs-exposed bronchitic rats. Healthy and bronchitic rats exposed to ROFA (approximately 1 mg/m3) did not show significant pulmonary injury (#E). Analysis of leachable elemental components of CAPs revealed the presence of sulfur, zinc, manganese, and iron. There was an apparent lack of association between pulmonary injury and CAPs concentration, or its leachable sulfate or elemental content. In summary, real-time atmospheric PM may result in pulmonary injury, particularly in susceptible models. However, the variability observed in pulmonary responses to CAPs emphasizes the need to conduct repeated studies, perhaps in relation to the season, as composition of CAPs may vary. Additionally, potential variability in pathology of induced bronchitis or other lung disease may decrease the ability to distinguish toxic injury due to PM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774827     DOI: 10.1093/toxsci/54.2.441

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  14 in total

1.  Toxicological evaluation of realistic emission source aerosols (TERESA): introduction and overview.

Authors:  John J Godleski; Annette C Rohr; Choong M Kang; Edgar A Diaz; Pablo A Ruiz; Petros Koutrakis
Journal:  Inhal Toxicol       Date:  2011-06-03       Impact factor: 2.724

2.  In vitro and in vivo assessment of pulmonary risk associated with exposure to combustion generated fine particles.

Authors:  Baher Fahmy; Liren Ding; Dahui You; Slawo Lomnicki; Barry Dellinger; Stephania A Cormier
Journal:  Environ Toxicol Pharmacol       Date:  2010-03       Impact factor: 4.860

3.  Toxicological evaluation of realistic emission source aerosols (TERESA)-power plant studies: assessment of cellular responses.

Authors:  John J Godleski; Edgar A Diaz; Miriam Lemos; Mark Long; Pablo Ruiz; Tarun Gupta; Choong-Min Kang; Brent Coull
Journal:  Inhal Toxicol       Date:  2011-04-05       Impact factor: 2.724

4.  Perinatal sulfur dioxide exposure alters brainstem parasympathetic control of heart rate.

Authors:  Amanda L Woerman; David Mendelowitz
Journal:  Cardiovasc Res       Date:  2013-03-14       Impact factor: 10.787

5.  Differential lung inflammation and injury with tobacco smoke exposure in Wistar Kyoto and spontaneously hypertensive rats.

Authors:  Alexa K Pham; Ching-Wen Wu; Xing Qiu; Jingyi Xu; Suzette Smiley-Jewell; Dale Uyeminami; Priya Upadhyay; Dewei Zhao; Kent E Pinkerton
Journal:  Inhal Toxicol       Date:  2020-08-11       Impact factor: 2.724

6.  Heavy metals zinc, cadmium, and copper stimulate pulmonary sensory neurons via direct activation of TRPA1.

Authors:  Qihai Gu; Ruei-Lung Lin
Journal:  J Appl Physiol (1985)       Date:  2010-02-04

7.  Statin Attenuated Myocardial Inflammation Induced by PM2.5 in Rats.

Authors:  Hongmei Yao; Jiyuan Lv
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

8.  Susceptibility Variations in Air Pollution Health Effects: Incorporating Neuroendocrine Activation.

Authors:  Urmila P Kodavanti
Journal:  Toxicol Pathol       Date:  2019-10-08       Impact factor: 1.930

9.  Consistent pulmonary and systemic responses from inhalation of fine concentrated ambient particles: roles of rat strains used and physicochemical properties.

Authors:  Urmila P Kodavanti; Mette C Schladweiler; Allen D Ledbetter; John K McGee; Leon Walsh; Peter S Gilmour; Jerry W Highfill; David Davies; Kent E Pinkerton; Judy H Richards; Kay Crissman; Debora Andrews; Daniel L Costa
Journal:  Environ Health Perspect       Date:  2005-11       Impact factor: 9.031

10.  Chronic cough due to occupational factors.

Authors:  David A Groneberg; Dennis Nowak; Anke Wussow; Axel Fischer
Journal:  J Occup Med Toxicol       Date:  2006-02-02       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.